0 XP   0   0   0

4Front Ventures Corp
Buy, Hold or Sell?

I guess you are interested in 4Front Ventures Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse 4Front Ventures Corp

Let's start. I'm going to help you getting a better view of 4Front Ventures Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is 4Front Ventures Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how 4Front Ventures Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value 4Front Ventures Corp. The closing price on 2022-10-03 was $0.34 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
4Front Ventures Corp Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of 4Front Ventures Corp.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit 4Front Ventures Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -23.0% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 4Front Ventures Corp:

  • The MRQ is -23.0%. The company is making a huge loss. -2
  • The TTM is -30.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-23.0%TTM-30.2%+7.2%
TTM-30.2%YOY-78.3%+48.1%
TTM-30.2%5Y-153.8%+123.6%
5Y-153.8%10Y-153.8%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.0%-0.9%-22.1%
TTM-30.2%0.3%-30.5%
YOY-78.3%0.1%-78.4%
5Y-153.8%-0.9%-152.9%
10Y-153.8%-0.3%-153.5%
1.1.2. Return on Assets

Shows how efficient 4Front Ventures Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -2.0% Return on Assets means that 4Front Ventures Corp generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 4Front Ventures Corp:

  • The MRQ is -2.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-3.2%+1.1%
TTM-3.2%YOY-7.0%+3.9%
TTM-3.2%5Y-8.1%+4.9%
5Y-8.1%10Y-8.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%0.1%-2.1%
TTM-3.2%0.1%-3.3%
YOY-7.0%-0.1%-6.9%
5Y-8.1%-0.2%-7.9%
10Y-8.1%-0.1%-8.0%
1.1.3. Return on Equity

Shows how efficient 4Front Ventures Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -12.0% Return on Equity means 4Front Ventures Corp generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 4Front Ventures Corp:

  • The MRQ is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.0%TTM-18.9%+7.0%
TTM-18.9%YOY-32.8%+13.9%
TTM-18.9%5Y-23.9%+5.0%
5Y-23.9%10Y-23.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.0%0.6%-12.6%
TTM-18.9%0.4%-19.3%
YOY-32.8%0.4%-33.2%
5Y-23.9%-0.3%-23.6%
10Y-23.9%0.1%-24.0%

1.2. Operating Efficiency of 4Front Ventures Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient 4Front Ventures Corp is operating .

  • Measures how much profit 4Front Ventures Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -7.3% means the company generated $-0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 4Front Ventures Corp:

  • The MRQ is -7.3%. The company is operating very inefficient. -2
  • The TTM is -16.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-16.4%+9.0%
TTM-16.4%YOY-5.8%-10.5%
TTM-16.4%5Y-142.7%+126.3%
5Y-142.7%10Y-142.7%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%2.5%-9.8%
TTM-16.4%1.6%-18.0%
YOY-5.8%2.7%-8.5%
5Y-142.7%2.0%-144.7%
10Y-142.7%1.3%-144.0%
1.2.2. Operating Ratio

Measures how efficient 4Front Ventures Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.64 means that the operating costs are $1.64 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 4Front Ventures Corp:

  • The MRQ is 1.640. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.744. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.640TTM1.744-0.103
TTM1.744YOY1.430+0.314
TTM1.7445Y2.529-0.785
5Y2.52910Y2.5290.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6401.497+0.143
TTM1.7441.446+0.298
YOY1.4301.389+0.041
5Y2.5291.370+1.159
10Y2.5291.182+1.347

1.3. Liquidity of 4Front Ventures Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if 4Front Ventures Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.74 means the company has $0.74 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 4Front Ventures Corp:

  • The MRQ is 0.743. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.875. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.743TTM0.875-0.132
TTM0.875YOY1.207-0.332
TTM0.8755Y1.430-0.555
5Y1.43010Y1.4300.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7431.902-1.159
TTM0.8751.908-1.033
YOY1.2072.112-0.905
5Y1.4302.173-0.743
10Y1.4301.891-0.461
1.3.2. Quick Ratio

Measures if 4Front Ventures Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.15 means the company can pay off $0.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 4Front Ventures Corp:

  • The MRQ is 0.146. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.129. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.146TTM0.129+0.017
TTM0.129YOY0.259-0.130
TTM0.1295Y0.303-0.174
5Y0.30310Y0.3030.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1460.667-0.521
TTM0.1290.792-0.663
YOY0.2590.819-0.560
5Y0.3030.838-0.535
10Y0.3030.823-0.520

1.4. Solvency of 4Front Ventures Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of 4Front Ventures Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.83 means that 4Front Ventures Corp assets are financed with 82.9% credit (debt) and the remaining percentage (100% - 82.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 4Front Ventures Corp:

  • The MRQ is 0.829. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.814. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.829TTM0.814+0.015
TTM0.814YOY0.758+0.055
TTM0.8145Y0.596+0.217
5Y0.59610Y0.5960.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8290.433+0.396
TTM0.8140.425+0.389
YOY0.7580.396+0.362
5Y0.5960.402+0.194
10Y0.5960.404+0.192
1.4.2. Debt to Equity Ratio

Measures if 4Front Ventures Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 484.4% means that company has $4.84 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 4Front Ventures Corp:

  • The MRQ is 4.844. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.554. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.844TTM4.554+0.290
TTM4.554YOY3.253+1.301
TTM4.5545Y2.081+2.473
5Y2.08110Y2.0810.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8440.668+4.176
TTM4.5540.677+3.877
YOY3.2530.624+2.629
5Y2.0810.686+1.395
10Y2.0810.705+1.376

2. Market Valuation of 4Front Ventures Corp

2. Earnings
2.1. Price to Earnings Ratio

Measures how much money you pays for each share for every $1 in earnings 4Front Ventures Corp generates.

  • Above 15 is considered overpriced but always compare 4Front Ventures Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -13.46 means the investor is paying $-13.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 4Front Ventures Corp:

  • The EOD is -6.183. Company is losing money. -2
  • The MRQ is -13.458. Company is losing money. -2
  • The TTM is -13.184. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-6.183MRQ-13.458+7.274
MRQ-13.458TTM-13.184-0.274
TTM-13.184YOY-8.714-4.470
TTM-13.1845Y-37.019+23.836
5Y-37.01910Y-37.0190.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-6.183-0.010-6.173
MRQ-13.458-0.067-13.391
TTM-13.184-0.006-13.178
YOY-8.714-0.031-8.683
5Y-37.0193.518-40.537
10Y-37.0194.263-41.282
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of 4Front Ventures Corp.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of 4Front Ventures Corp:

  • The MRQ is 0.289. Very good. +2
  • The TTM is 0.366. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.366-0.076
TTM0.366YOY0.148+0.217
TTM0.3665Y0.154+0.212
5Y0.15410Y0.1540.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2890.003+0.286
TTM0.3660.019+0.347
YOY0.1480.024+0.124
5Y0.1540.023+0.131
10Y0.1540.026+0.128

2. Books
2.3. Price to Book Ratio

Measures if the stock price of 4Front Ventures Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 8.60 means the investor is paying $8.60 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 4Front Ventures Corp:

  • The EOD is 3.951. Neutral. Compare to industry.
  • The MRQ is 8.598. Seems overpriced? -1
  • The TTM is 11.572. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD3.951MRQ8.598-4.648
MRQ8.598TTM11.572-2.974
TTM11.572YOY10.451+1.121
TTM11.5725Y4.996+6.576
5Y4.99610Y4.9960.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD3.9511.407+2.544
MRQ8.5981.588+7.010
TTM11.5722.019+9.553
YOY10.4512.258+8.193
5Y4.9961.986+3.010
10Y4.9961.531+3.465

3. Summary

3.1. Key Performance Indicators

The key performance indicators of 4Front Ventures Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0860.080+7%0.092-7%0.051+69%0.051+69%
Book Value Per Share Growth--0.001-0.001+207%-0.009+1059%0.008-88%0.008-88%
Current Ratio--0.7430.875-15%1.207-38%1.430-48%1.430-48%
Debt To Asset Ratio--0.8290.814+2%0.758+9%0.596+39%0.596+39%
Debt To Equity Ratio--4.8444.554+6%3.253+49%2.081+133%2.081+133%
Dividend Per Share----0%-0%-0%-0%
Eps---0.010-0.014+34%-0.026+150%-0.019+88%-0.019+88%
Eps Growth---46.507-38.889-16%16.504-382%435.387-111%435.387-111%
Gains Per Share--0.001-0.001+207%-0.009+1059%0.008-88%0.008-88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.230-0.302+31%-0.783+240%-1.538+568%-1.538+568%
Operating Margin---0.073-0.164+123%-0.058-20%-1.427+1842%-1.427+1842%
Operating Ratio--1.6401.744-6%1.430+15%2.529-35%2.529-35%
Pb Ratio3.951-118%8.59811.572-26%10.451-18%4.996+72%4.996+72%
Pe Ratio-6.183+54%-13.458-13.184-2%-8.714-35%-37.019+175%-37.019+175%
Peg Ratio--0.2890.366-21%0.148+95%0.154+88%0.154+88%
Price Per Share0.340-118%0.7400.902-18%0.907-18%0.804-8%0.804-8%
Quick Ratio--0.1460.129+14%0.259-43%0.303-52%0.303-52%
Return On Assets---0.020-0.032+55%-0.070+244%-0.081+297%-0.081+297%
Return On Equity---0.120-0.189+58%-0.328+175%-0.239+100%-0.239+100%
 EOD+2 -1MRQTTM+14 -4YOY+9 -95Y+8 -1010Y+8 -10

3.2. Fundamental Score

Let's check the fundamental score of 4Front Ventures Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.183
Price to Book Ratio (EOD)Between0-13.951
Net Profit Margin (MRQ)Greater than0-0.230
Operating Margin (MRQ)Greater than0-0.073
Quick Ratio (MRQ)Greater than10.146
Current Ratio (MRQ)Greater than10.743
Debt to Asset Ratio (MRQ)Less than10.829
Debt to Equity Ratio (MRQ)Less than14.844
Return on Equity (MRQ)Greater than0.15-0.120
Return on Assets (MRQ)Greater than0.05-0.020
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of 4Front Ventures Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.116
Ma 20Greater thanMa 500.415
Ma 50Greater thanMa 1000.508
Ma 100Greater thanMa 2000.570
OpenGreater thanClose0.305
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-04-30. Currency in USD. All numbers in thousands.

Summary
Total Assets320,457
Total Liabilities265,555
Total Stockholder Equity54,820
 As reported
Total Liabilities 265,555
Total Stockholder Equity+ 54,820
Total Assets = 320,457

Assets

Total Assets320,457
Total Current Assets47,125
Long-term Assets47,125
Total Current Assets
Cash And Cash Equivalents 6,032
Net Receivables 9,282
Inventory 28,837
Total Current Assets  (as reported)47,125
Total Current Assets  (calculated)44,151
+/- 2,974
Long-term Assets
Property Plant Equipment 165,373
Goodwill 42,037
Intangible Assets 54,239
Other Assets 11,683
Long-term Assets  (as reported)273,332
Long-term Assets  (calculated)273,332
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities63,392
Long-term Liabilities202,163
Total Stockholder Equity54,820
Total Current Liabilities
Short Long Term Debt 8,235
Accounts payable 6,391
Other Current Liabilities 31,614
Total Current Liabilities  (as reported)63,392
Total Current Liabilities  (calculated)46,240
+/- 17,152
Long-term Liabilities
Long term Debt 74,699
Capital Lease Obligations Min Short Term Debt105,501
Other Liabilities 10,084
Long-term Liabilities Other 16,000
Long-term Liabilities  (as reported)202,163
Long-term Liabilities  (calculated)206,284
+/- 4,121
Total Stockholder Equity
Common Stock302,502
Retained Earnings -301,307
Total Stockholder Equity (as reported)54,820
Total Stockholder Equity (calculated)1,195
+/- 53,625
Other
Capital Stock302,502
Common Stock Shares Outstanding 637,913
Net Debt 76,902
Net Invested Capital 137,754
Net Tangible Assets -41,456
Net Working Capital -16,267



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-03-312019-01-312018-12-312018-10-312018-09-302018-07-312017-10-31
> Total Assets 
13,779
46,904
24,296
43,299
65,016
65,084
81,795
113,656
343,157
203,919
215,558
216,580
209,903
204,756
208,922
208,764
212,112
255,539
290,689
320,457
320,457290,689255,539212,112208,764208,922204,756209,903216,580215,558203,919343,157113,65681,79565,08465,01643,29924,29646,90413,779
   > Total Current Assets 
3,843
14,134
4,372
12,830
10,723
30,950
14,430
34,612
32,264
31,741
38,934
48,222
42,202
44,736
44,254
41,663
43,267
50,874
43,809
47,125
47,12543,80950,87443,26741,66344,25444,73642,20248,22238,93431,74132,26434,61214,43030,95010,72312,8304,37214,1343,843
       Cash And Cash Equivalents 
3,609
11,107
2,346
10,044
1,263
27,847
3,831
2,400
5,994
5,789
9,288
11,434
8,499
18,932
17,806
11,563
8,477
22,581
8,638
6,032
6,0328,63822,5818,47711,56317,80618,9328,49911,4349,2885,7895,9942,4003,83127,8471,26310,0442,34611,1073,609
       Short-term Investments 
0
0
0
0
0
0
0
0
6,540
0
0
0
0
0
0
0
0
0
0
0
000000000006,54000000000
       Net Receivables 
90
2,569
1,771
2,012
4,410
1,973
4,557
2,507
1,528
12,429
13,863
12,970
16,441
5,492
4,372
5,275
5,390
5,974
7,182
9,282
9,2827,1825,9745,3905,2754,3725,49216,44112,97013,86312,4291,5282,5074,5571,9734,4102,0121,7712,56990
       Inventory 
19
111
116
74
4,784
319
5,837
7,383
9,151
11,325
13,864
14,637
15,594
18,037
18,971
22,600
27,006
20,087
25,910
28,837
28,83725,91020,08727,00622,60018,97118,03715,59414,63713,86411,3259,1517,3835,8373194,7847411611119
   > Long-term Assets 
0
0
0
0
0
0
0
79,043
310,893
172,178
176,624
168,358
165,396
160,020
164,668
167,101
168,845
204,665
246,880
273,332
273,332246,880204,665168,845167,101164,668160,020165,396168,358176,624172,178310,89379,0430000000
       Property Plant Equipment 
5,506
29,826
8,912
29,408
13,581
28,830
18,604
22,800
83,903
62,298
77,787
71,968
71,260
96,084
101,135
104,971
107,664
143,152
157,210
165,373
165,373157,210143,152107,664104,971101,13596,08471,26071,96877,78762,29883,90322,80018,60428,83013,58129,4088,91229,8265,506
       Goodwill 
0
0
0
0
6,066
0
12,291
12,299
188,942
33,988
28,854
28,854
28,854
23,155
23,155
23,155
23,155
23,155
33,404
42,037
42,03733,40423,15523,15523,15523,15523,15528,85428,85428,85433,988188,94212,29912,29106,0660000
       Long Term Investments 
0
0
0
755
0
982
0
1,154
750
759
759
759
759
0
0
0
0
0
0
0
00000007597597597597501,15409820755000
       Intangible Assets 
1,141
0
1,141
0
21,894
0
21,699
26,941
29,401
41,442
40,665
39,888
39,197
28,790
28,207
27,524
26,883
26,246
43,616
54,239
54,23943,61626,24626,88327,52428,20728,79039,19739,88840,66541,44229,40126,94121,699021,89401,14101,141
       Long-term Assets Other 
0
0
0
0
0
34,134
0
79,043
310,893
2,352
0
0
0
0
0
0
0
0
0
0
00000000002,352310,89379,043034,13400000
> Total Liabilities 
14,335
13,075
5,582
8,626
12,346
29,937
30,694
63,281
104,031
127,940
145,580
152,229
146,671
162,553
166,559
155,196
160,533
218,007
237,152
265,555
265,555237,152218,007160,533155,196166,559162,553146,671152,229145,580127,940104,03163,28130,69429,93712,3468,6265,58213,07514,335
   > Total Current Liabilities 
4,532
6,215
5,025
3,175
12,068
15,864
26,201
25,031
16,294
18,851
23,729
22,362
24,297
37,784
44,243
45,923
49,964
48,838
51,612
63,392
63,39251,61248,83849,96445,92344,24337,78424,29722,36223,72918,85116,29425,03126,20115,86412,0683,1755,0256,2154,532
       Short-term Debt 
0
0
0
0
0
0
0
20,663
7,204
0
0
0
0
0
0
0
0
0
0
0
000000000007,20420,6630000000
       Short Long Term Debt 
0
2,008
0
1,072
0
0
0
20,663
7,204
7,382
9,766
6,750
8,026
5,024
6,012
6,539
6,817
6,197
5,385
8,235
8,2355,3856,1976,8176,5396,0125,0248,0266,7509,7667,3827,20420,6630001,07202,0080
       Accounts payable 
401
1,159
868
228
1,283
1,611
1,304
2,224
3,931
8,138
9,414
6,591
3,095
4,722
6,576
5,484
4,716
2,131
5,110
6,391
6,3915,1102,1314,7165,4846,5764,7223,0956,5919,4148,1383,9312,2241,3041,6111,2832288681,159401
       Other Current Liabilities 
181
3,000
189
1,828
877
13,957
994
313
127
2,359
3,319
8,050
9,468
19,702
21,647
27,204
28,728
27,470
29,821
31,614
31,61429,82127,47028,72827,20421,64719,7029,4688,0503,3192,35912731399413,9578771,8281893,000181
   > Long-term Liabilities 
0
0
0
0
0
14,074
0
38,250
87,737
109,089
121,851
129,867
122,410
124,769
122,316
109,273
110,569
169,169
185,540
202,163
202,163185,540169,169110,569109,273122,316124,769122,410129,867121,851109,08987,73738,250014,07400000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
-15,625
14,070
21,948
34,518
32,729
26,890
53,454
53,129
52,976
54,181
96,740
97,205
105,501
105,50197,20596,74054,18152,97653,12953,45426,89032,72934,51821,94814,070-15,6250000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,000
16,000
16,00016,000000000000000000000
> Total Stockholder Equity
-348
33,829
19,066
34,672
53,317
35,146
52,936
50,432
239,190
76,184
70,201
64,642
63,232
42,151
42,306
53,506
51,512
37,460
53,460
54,820
54,82053,46037,46051,51253,50642,30642,15163,23264,64270,20176,184239,19050,43252,93635,14653,31734,67219,06633,829-348
   Common Stock
11,102
32,540
38,350
32,470
72,236
32,470
76,471
80,750
274,942
252,656
252,656
238,995
240,362
250,583
259,431
273,875
273,877
274,120
294,981
302,502
302,502294,981274,120273,877273,875259,431250,583240,362238,995252,656252,656274,94280,75076,47132,47072,23632,47038,35032,54011,102
   Retained Earnings -301,307-294,756-288,857-272,459-267,860-261,637-250,548-215,938-208,464-210,238-202,090-35,752-28,888-23,536-9,459-18,919-1,794-19,284-2,491-11,451
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
3,780
0
3,996
0
5,319
0
7,357
0
25,618
27,783
34,111
32,708
0
0
0
0
0
0
0
000000032,70834,11127,78325,61807,35705,31903,99603,7800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-04-30)

Gross Profit (+$)
totalRevenue104,566
Cost of Revenue-55,170
Gross Profit49,39649,396
 
Operating Income (+$)
Gross Profit49,396
Operating Expense-118,672
Operating Income-14,106-69,276
 
Operating Expense (+$)
Research Development-
Selling General Administrative58,400
Selling And Marketing Expenses-
Operating Expense118,67258,400
 
Net Interest Income (+$)
Interest Income15
Interest Expense-13,704
Net Interest Income-13,689-13,689
 
Pretax Income (+$)
Operating Income-14,106
Net Interest Income-13,689
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-24,358-17,543
EBIT - interestExpense = -27,810
-24,378
-24,605
Interest Expense13,704
Earnings Before Interest and Taxes (ebit)-14,106-10,654
Earnings Before Interest and Taxes (ebitda)-4,018
 
After tax Income (+$)
Income Before Tax-24,358
Tax Provision-13,931
Net Income From Continuing Ops-38,289-38,289
Net Income-38,309
Net Income Applicable To Common Shares-38,309
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net3,43713,689
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
WATR.LSE
now

I found you a STOCH Bearish Hidden Divergence on the daily chart of WATR.LSE.

WATR.LSE Daily Candlestick Chart
TRT.LSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TRT.LSE.

TRT.LSE Daily Candlestick Chart
PHSP.LSE
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHSP.LSE.

PHSP.LSE Daily Candlestick Chart
PHAG.LSE
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHAG.LSE.

PHAG.LSE Daily Candlestick Chart
PFD.LSE
2 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of PFD.LSE.

PFD.LSE Daily Candlestick Chart
PAG.LSE
2 minutes ago

I found you a Death Cross on the daily chart of PAG.LSE.

PAG.LSE Daily Candlestick Chart
ITV.LSE
3 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of ITV.LSE.

ITV.LSE Daily Candlestick Chart
IAPD.LSE
3 minutes ago

I found you a Death Cross on the daily chart of IAPD.LSE.

IAPD.LSE Daily Candlestick Chart
IBGS.LSE
3 minutes ago

I found you a Golden Cross on the daily chart of IBGS.LSE.

IBGS.LSE Daily Candlestick Chart
HTG.LSE
3 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of HTG.LSE.

HTG.LSE Daily Candlestick Chart
FRES.LSE
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRES.LSE.

FRES.LSE Daily Candlestick Chart
EME.LSE
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of EME.LSE.

EME.LSE Daily Candlestick Chart
DTY.LSE
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DTY.LSE.

DTY.LSE Daily Candlestick Chart
DRX.LSE
5 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DRX.LSE.

DRX.LSE Daily Candlestick Chart
COG.LSE
6 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of COG.LSE.

COG.LSE Daily Candlestick Chart
CRST.LSE
6 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of CRST.LSE.

CRST.LSE Daily Candlestick Chart
3LSI.LSE
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3LSI.LSE.

3LSI.LSE Daily Candlestick Chart
FORTUM.HE
7 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of FORTUM.HE.

FORTUM.HE Daily Candlestick Chart
HOME.LSE
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HOME.LSE.

HOME.LSE Daily Candlestick Chart
ADMCM.HE
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ADMCM.HE.

ADMCM.HE Daily Candlestick Chart
LLN.MC
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LLN.MC.

LLN.MC Daily Candlestick Chart
LGT.MC
7 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of LGT.MC.

LGT.MC Daily Candlestick Chart
ENO.MC
7 minutes ago

I found you a Death Cross on the daily chart of ENO.MC.

ENO.MC Daily Candlestick Chart
ENG.MC
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ENG.MC.

ENG.MC Daily Candlestick Chart